Table 3.
The relative expressions of YAP1 mRNA, E-cadherin mRNA, and vimentin mRNA in the two sets of patients (x̅ ± s)
| Group | Number of cases | YAP1 mRNA | E-cadherin mRNA | vimentin mRNA |
|---|---|---|---|---|
| Nasal-polyps group | 58 | 2.107±0.337 | 0.729±0.164 | 1.478±0.251 |
| Control group | 30 | 1.264±0.283 | 1.527±0.301 | 0.920±0.231 |
| t | - | 11.721 | 16.133 | 10.151 |
| P | - | 0.000 | 0.000 | 0.000 |